1. Neuroscience
Download icon

Subthalamic beta targeted neurofeedback speeds up movement initiation but increases tremor in Parkinsonian patients

  1. Shenghong He
  2. Abteen Mostofi
  3. Emilie Syed
  4. Flavie Torrecillos
  5. Gerd Tinkhauser
  6. Petra Fischer
  7. Alek Pogosyan
  8. Harutomo Hasegawa
  9. Yuanqing Li
  10. Keyoumars Ashkan
  11. Erlick Pereira
  12. Peter Brown  Is a corresponding author
  13. Huiling Tan  Is a corresponding author
  1. University of Oxford, United Kingdom
  2. St George's University of London, United Kingdom
  3. Nuffield Dep of Clinical Neurosciences and MRC BNDU, United Kingdom
  4. King's College Hospital NHS Foundation Trust, United Kingdom
  5. South China University of Technology, China
  6. Kings College London, United Kingdom
Research Article
  • Cited 0
  • Views 811
  • Annotations
Cite this article as: eLife 2020;9:e60979 doi: 10.7554/eLife.60979

Abstract

Previous studies have explored neurofeedback training for Parkinsonian patients to suppress beta oscillations in the subthalamic nucleus (STN). However, its impacts on movements and Parkinsonian tremor are unclear. We developed a neurofeedback paradigm targeting STN beta bursts and investigated whether neurofeedback training could improve motor initiation in Parkinson's disease compared to passive observation. Our task additionally allowed us to test which endogenous changes in oscillatory STN activities are associated with trial-to-trial motor performance. Neurofeedback training reduced beta synchrony and increased gamma activity within the STN, and reduced beta band coupling between the STN and motor cortex. These changes were accompanied by reduced reaction times in subsequently cued movements. However, in Parkinsonian patients with pre-existing symptoms of tremor, successful volitional beta suppression was associated with an amplification of tremor which correlated with theta band activity in STN LFPs, suggesting an additional cross-frequency interaction between STN beta and theta activities.

Article and author information

Author details

  1. Shenghong He

    Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  2. Abteen Mostofi

    Neurosciences Research Centre, St George's University of London, London, United Kingdom
    Competing interests
    No competing interests declared.
  3. Emilie Syed

    Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  4. Flavie Torrecillos

    Clinical Neurosciences, Nuffield Dep of Clinical Neurosciences and MRC BNDU, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  5. Gerd Tinkhauser

    Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  6. Petra Fischer

    Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5585-8977
  7. Alek Pogosyan

    Nuffield Department of Clinical Neuroscience; 2. Medical Research Council Brain Network Dynamics Unit, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  8. Harutomo Hasegawa

    Department of Neurosurgery, King's College Hospital NHS Foundation Trust, London, United Kingdom
    Competing interests
    No competing interests declared.
  9. Yuanqing Li

    School of Automation Science and Engineering, South China University of Technology, Guangzhou, China
    Competing interests
    No competing interests declared.
  10. Keyoumars Ashkan

    Department of Neurosurgery, Kings College Hospital, Kings College London, London, United Kingdom
    Competing interests
    Keyoumars Ashkan, has received educational grants from Medtronic and Abbott.
  11. Erlick Pereira

    Neurosciences Research Centre, St George's University of London, London, United Kingdom
    Competing interests
    No competing interests declared.
  12. Peter Brown

    Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom
    For correspondence
    peter.brown@ndcn.ox.ac.uk
    Competing interests
    Peter Brown, is a consultant for Medtronic..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5201-3044
  13. Huiling Tan

    Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
    For correspondence
    huiling.tan@ndcn.ox.ac.uk
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8038-3029

Funding

Medical Research Council (MR/P012272/1)

  • Shenghong He
  • Huiling Tan

Medical Research Council (MC_UU_12024/1)

  • Flavie Torrecillos
  • Gerd Tinkhauser
  • Petra Fischer
  • Alek Pogosyan
  • Peter Brown

National Institute for Health Research (Oxford Biomedical Research Centre)

  • Shenghong He
  • Abteen Mostofi
  • Emilie Syed
  • Flavie Torrecillos
  • Gerd Tinkhauser
  • Petra Fischer
  • Alek Pogosyan
  • Peter Brown
  • Huiling Tan

Rosetrees Trust

  • Shenghong He
  • Huiling Tan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Informed consent and consent to publish was obtained from patients before they took part in the study, which was approved by Oxfordshire Research Ethics Committee, reference number 18/SC/0006.

Reviewing Editor

  1. Preeya Khanna, University of California, Berkeley, United States

Publication history

  1. Received: July 12, 2020
  2. Accepted: November 16, 2020
  3. Accepted Manuscript published: November 18, 2020 (version 1)
  4. Version of Record published: November 27, 2020 (version 2)

Copyright

© 2020, He et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 811
    Page views
  • 163
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Neuroscience
    Timothy S Balmer et al.
    Research Article Updated

    Synapses of glutamatergic mossy fibers (MFs) onto cerebellar unipolar brush cells (UBCs) generate slow excitatory (ON) or inhibitory (OFF) postsynaptic responses dependent on the complement of glutamate receptors expressed on the UBC’s large dendritic brush. Using mouse brain slice recording and computational modeling of synaptic transmission, we found that substantial glutamate is maintained in the UBC synaptic cleft, sufficient to modify spontaneous firing in OFF UBCs and tonically desensitize AMPARs of ON UBCs. The source of this ambient glutamate was spontaneous, spike-independent exocytosis from the MF terminal, and its level was dependent on activity of glutamate transporters EAAT1–2. Increasing levels of ambient glutamate shifted the polarity of evoked synaptic responses in ON UBCs and altered the phase of responses to in vivo-like synaptic activity. Unlike classical fast synapses, receptors at the UBC synapse are virtually always exposed to a significant level of glutamate, which varies in a graded manner during transmission.

    1. Developmental Biology
    2. Neuroscience
    Hiroki Takechi et al.
    Research Article

    Transmembrane protein Golden goal (Gogo) interacts with atypical cadherin Flamingo to direct R8 photoreceptor axons in the Drosophila visual system. However, the precise mechanisms underlying Gogo regulation during columnar- and layer-specific R8 axon targeting are unknown. Our studies demonstrated that the insulin secreted from surface and cortex glia switches the phosphorylation status of Gogo, thereby regulating its two distinct functions. Non-phosphorylated Gogo mediates the initial recognition of the glial protrusion in the center of the medulla column, whereas phosphorylated Gogo suppresses radial filopodia extension by counteracting Flamingo to maintain a one axon to one column ratio. Later, Gogo expression ceases during the midpupal stage, thus allowing R8 filopodia to extend vertically into the M3 layer. These results demonstrate that the long- and short-range signaling between the glia and R8 axon growth cones regulates growth cone dynamics in a stepwise manner, and thus shape the entire organization of the visual system.